SUBSCRIBERS
Big Pharma losing price leverage amid squeeze by payers
Latest quarterly results raise pressure on drugmakers to pump up sales volumes, find lucrative new treatments
Published Thu, May 4, 2017 · 09:50 PM
New York
BEING a big drug company isn't what it used to be.
The largest drugmakers are finding it more difficult to charge high prices for a range of medications, their latest quarterly results show. That's raising the pressure to pump up sales volumes and find lucrative new treatments for niche markets.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
HCA beats first-quarter profit estimates on higher patient admissions
US FDA approves Pfizer’s gene therapy for rare bleeding disorder
EU toughens rules on Chinese fashion retailer Shein
Best World under fire from shareholders at AGM over dividends, director salaries
‘Extreme’ climate blamed for world’s worst wine harvest in 62 years
Sheng Siong Q1 net profit up 9.3% on higher revenue